GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » Total Current Liabilities

VRHI (Veri Medtech Holdings) Total Current Liabilities : $0.27 Mil (As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Veri Medtech Holdings's total current liabilities for the quarter that ended in Dec. 2021 was $0.27


Veri Medtech Holdings Total Current Liabilities Historical Data

The historical data trend for Veri Medtech Holdings's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veri Medtech Holdings Total Current Liabilities Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Total Current Liabilities
0.27

Veri Medtech Holdings Semi-Annual Data
Dec21
Total Current Liabilities 0.27

Veri Medtech Holdings Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Veri Medtech Holdings's Total Current Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.272+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.27

Veri Medtech Holdings's Total Current Liabilities for the quarter that ended in Dec. 2021 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.272+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Veri Medtech Holdings Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Veri Medtech Holdings's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Veri Medtech Holdings Business Description

Traded in Other Exchanges
N/A
Address
1660 International Dr, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines